PDS Biotechnology's total assets for Q1 2025 were $47.03M, an increase of 3.68% from the previous quarter. PDSB total liabilities were $24.67M for the fiscal quarter, a -6.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.